22 Nov 2019

The Association of the British Pharmaceutical Industry (ABPI) identifies “high standards for transparency” as one of seven key factors required to maintain the UK’s position as an "attractive destination for global investment in the sector".

According to a new policy paper published by ABPI:

A key element of research transparency is registration and reporting on international da...

21 Nov 2019

Irish medical schools have made the results of over 85% of their clinical trials available on the European trial registry, making Irish universities the strongest transparency performers in the whole of Europe.

Irish universities’ reporting rate of 85.7% places it ahead of academic institutions in the UK, which have uploaded the results of 72.1% of their trials. In contrast, les...

19 Nov 2019

In our recent systematic review of 204 clinical trials involving venous leg ulcers published in 76 journals since 2001, we found that over 80% of trials had not been registered.

This included trials of drugs, medical devices, and other interventions.

Only 38 of the trials in our review reported registration, while 166 trials were not registered. Registration rates have been incr...

8 Nov 2019

Failure to register and report clinical trials is not a victimless crime. It harms patients, undermines public health, slows down medical progress, and wastes public funds.

Nonetheless, not a single institution has ever been fined, anywhere in the world, for violating universally recognised ethical obligations.

During a recent parliamentary hearing in the UK, the issue of sanctio...

7 Nov 2019

Many scientists secretly believe that politicians are too daft to understand the complexities and challenges of doing science well.

Last week, UK parliamentarians proved them wrong when they quizzed universities and regulators about their progress on making more clinical trial results public.

Below nine takeaways from the session.

Back story: In 2018, politicians were dismayed t...

1 Nov 2019

Evidence requirements and transparency of evidence for medical devices will probably improve under the incoming EU Medical Device Regulation, but will continue to fall short of the standards applied to medicines, a paper published by the British charity HealthWatch has found.

Issues covered in the paper:

  • Strengths and weaknesses of the Medical Device Regulation

  • Third par...

1 Nov 2019

While large pharmaceutical companies typically do well at making clinical trial results public on registries, many small companies still fall short of minimum regulatory standards.

The data below shows clinical trial reporting performance in the EU and US broken down by sponsor type:

  • In Europe, 66% of trials run by small companies are missing results, versus 76% of trials run...

31 Oct 2019

Dutch universities violate clinical trial transparency rules on a large scale, new data gathered by Universities Allied for Essential Medicines (UAEM) and Health Action International shows.

Dutch universities have sponsored 1,140 clinical trials, but have posted results for only two (!) of these trials. 

Furthermore, only 25 of the 1,140 clinical trials are listed on the Europea...

29 Oct 2019

The European Medicines Agency has announced plans to make it easier for universities and smaller pharma companies to upload the results of clinical trials of medicines onto the European trial registry EudraCT.

Posting results of onto the registry has been mandatory since 2014, but many institutions running clinical trials are violating this transparency rule, leaving large gaps...

25 Oct 2019

On Tuesday, UK parliament will assess progress in clinical trial reporting by universities and NHS Trusts. The session follows up on parliament’s 2018 enquiry into clinical trial transparency, and will be streamed live from 09:30 onwards.

Update: A transcript of the session is now available online.

Meanwhile, new compliance data shows substantial but uneven progress by non-commer...

The results of many clinical trials must be made public according to U.S. law. However, the law in question remains unenforced, leaving over five billion dollars in potential fines uncollected. In this guest blog, three scholars explain efforts to force the Food and Drug Administration’s hand by taking it to court.

Clinical trial transparency—in the form of publicly accessible t...

22 Oct 2019

Is achieving 100% clinical trial registration and results reporting a pipe dream? The answer is no – if national governments centrally monitor all clinical trials.

Unregistered and unreported clinical trials harm patients, undermine public health, and waste taxpayers’ money. Cases such as the $18 billion (mis)spent on Tamiflu worldwide underline the immense human and financial c...

21 Oct 2019

The results of around 500 clinical trials run by NHS Trusts remain unreported, an analysis of registry data combined with responses to Freedom of Information Requests indicates.

In total, medical discoveries that cost NHS Trusts and their funders over £250 million to generate may be at risk of becoming research waste. 

Medical research whose findings remain invisible fails to be...

16 Oct 2019

Concerns that uploading clinical trial results onto registries will prevent subsequent publication in journals are completely unfounded and an “urban legend”, experts say.

Some academic researchers still worry that if they make trial results public on registries like Clinicaltrials.gov or EudraCT before they have published them in academic journals, journal editors might then re...

15 Oct 2019

Since 2014, it has been mandatory for companies and universities running clinical trials of medicines to upload their results onto the European trial registry, which is managed by the European Medicines Agency.

However, most European universities have uploaded less than ten percent of their results. Small and mid-sized companies also have low compliance rates. According to the E...

Please reload

Recent Posts
Please reload

This site was designed with the
website builder. Create your website today.
Start Now